20,500 Shares in Danaher Corporation $DHR Purchased by Hikari Power Ltd

Hikari Power Ltd acquired a new position in shares of Danaher Corporation (NYSE:DHR) in the 2nd quarter, Holdings Channel.com reports. The firm acquired 20,500 shares of the conglomerate’s stock, valued at approximately $3,905,000. Danaher accounts for about 0.5% of Hikari Power Ltd’s holdings, making the stock its 17th biggest position.

A number of other large investors also recently added to or reduced their stakes in DHR. State Street Corp raised its stake in shares of Danaher by 1.7% during the fourth quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock worth $6,345,529,000 after buying an additional 472,608 shares during the last quarter. Capital International Investors boosted its stake in Danaher by 8.9% in the fourth quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock valued at $4,177,386,000 after acquiring an additional 1,487,768 shares during the last quarter. Price T Rowe Associates Inc. MD grew its holdings in Danaher by 9.1% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock worth $3,656,595,000 after acquiring an additional 1,334,221 shares during the period. Wellington Management Group LLP grew its holdings in Danaher by 11.2% during the 4th quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock worth $3,451,380,000 after acquiring an additional 1,517,904 shares during the period. Finally, Norges Bank bought a new stake in shares of Danaher during the 4th quarter valued at $2,177,106,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Trading Up 0.0%

Shares of NYSE DHR opened at $202.51 on Monday. The company’s fifty day moving average is $193.14 and its 200-day moving average is $192.91. The stock has a market cap of $142.37 billion, a price-to-earnings ratio of 35.97, a P/E/G ratio of 2.52 and a beta of 0.78. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The business had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm’s quarterly revenue was up 5.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.77 EPS. Equities research analysts predict that Danaher Corporation will post 8.53 EPS for the current year.

Analyst Upgrades and Downgrades

DHR has been the topic of a number of analyst reports. Citigroup started coverage on Danaher in a research note on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price target on the stock. Guggenheim decreased their price objective on Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $240.00 price objective on shares of Danaher in a report on Wednesday, July 22nd. Jefferies Financial Group restated a “buy” rating and set a $245.00 target price on shares of Danaher in a report on Tuesday, April 21st. Finally, Argus decreased their target price on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research report on Friday, April 24th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $228.91.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.